Cargando…
Clinical and Endoscopic Differences Between Patients With Barrett’s Esophagus With and Without Dysplasia/Adenocarcinoma
Introduction: Barrett's esophagus (BE) is the main precursor of esophageal adenocarcinoma (EAC). This study aimed to identify the risk factors associated with BE progression to dysplasia or EAC in a Latin population. Methods: The study is a retrospective analysis of a single-center cohort of pa...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617646/ https://www.ncbi.nlm.nih.gov/pubmed/37916254 http://dx.doi.org/10.7759/cureus.46323 |
_version_ | 1785129621862219776 |
---|---|
author | Valdovinos-Andraca, Francisco Bartnicki-Navarrete, Isaac Bernal-Mendez, Ambrosio R Rafael Barreto-Zuñiga, Rafael Romano-Munive, Adriana F Gamboa-Domínguez, Armando Elizondo-Rivera, Javier Briseño-García, Daniel Tellez-Ávila, Felix I |
author_facet | Valdovinos-Andraca, Francisco Bartnicki-Navarrete, Isaac Bernal-Mendez, Ambrosio R Rafael Barreto-Zuñiga, Rafael Romano-Munive, Adriana F Gamboa-Domínguez, Armando Elizondo-Rivera, Javier Briseño-García, Daniel Tellez-Ávila, Felix I |
author_sort | Valdovinos-Andraca, Francisco |
collection | PubMed |
description | Introduction: Barrett's esophagus (BE) is the main precursor of esophageal adenocarcinoma (EAC). This study aimed to identify the risk factors associated with BE progression to dysplasia or EAC in a Latin population. Methods: The study is a retrospective analysis of a single-center cohort of patients with BE, evaluated from 2002 to 2012. Results: We identified 420 patients with BE; 281 (66.9%) of them were men with a mean age of 57.2 ± 15.3 years. Among all BE patients evaluated, 81 (19.3%) had progression to some degree of dysplasia/EAC. The mean follow-up was 5.6 years. Multivariate analysis showed that age (OR = 1.03), cigarette smoking (OR = 3.05), long-segment BE (OR = 4.81), and a visible lesion on BE (OR = 6.94) were associated with progression to dysplasia/EAC. Conclusion: In Latin patients with BE, age, cigarette smoking, long-segment BE, and the presence of lesions were associated with the presence of dysplasia/EAC. |
format | Online Article Text |
id | pubmed-10617646 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-106176462023-11-01 Clinical and Endoscopic Differences Between Patients With Barrett’s Esophagus With and Without Dysplasia/Adenocarcinoma Valdovinos-Andraca, Francisco Bartnicki-Navarrete, Isaac Bernal-Mendez, Ambrosio R Rafael Barreto-Zuñiga, Rafael Romano-Munive, Adriana F Gamboa-Domínguez, Armando Elizondo-Rivera, Javier Briseño-García, Daniel Tellez-Ávila, Felix I Cureus Gastroenterology Introduction: Barrett's esophagus (BE) is the main precursor of esophageal adenocarcinoma (EAC). This study aimed to identify the risk factors associated with BE progression to dysplasia or EAC in a Latin population. Methods: The study is a retrospective analysis of a single-center cohort of patients with BE, evaluated from 2002 to 2012. Results: We identified 420 patients with BE; 281 (66.9%) of them were men with a mean age of 57.2 ± 15.3 years. Among all BE patients evaluated, 81 (19.3%) had progression to some degree of dysplasia/EAC. The mean follow-up was 5.6 years. Multivariate analysis showed that age (OR = 1.03), cigarette smoking (OR = 3.05), long-segment BE (OR = 4.81), and a visible lesion on BE (OR = 6.94) were associated with progression to dysplasia/EAC. Conclusion: In Latin patients with BE, age, cigarette smoking, long-segment BE, and the presence of lesions were associated with the presence of dysplasia/EAC. Cureus 2023-10-01 /pmc/articles/PMC10617646/ /pubmed/37916254 http://dx.doi.org/10.7759/cureus.46323 Text en Copyright © 2023, Valdovinos-Andraca et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Gastroenterology Valdovinos-Andraca, Francisco Bartnicki-Navarrete, Isaac Bernal-Mendez, Ambrosio R Rafael Barreto-Zuñiga, Rafael Romano-Munive, Adriana F Gamboa-Domínguez, Armando Elizondo-Rivera, Javier Briseño-García, Daniel Tellez-Ávila, Felix I Clinical and Endoscopic Differences Between Patients With Barrett’s Esophagus With and Without Dysplasia/Adenocarcinoma |
title | Clinical and Endoscopic Differences Between Patients With Barrett’s Esophagus With and Without Dysplasia/Adenocarcinoma |
title_full | Clinical and Endoscopic Differences Between Patients With Barrett’s Esophagus With and Without Dysplasia/Adenocarcinoma |
title_fullStr | Clinical and Endoscopic Differences Between Patients With Barrett’s Esophagus With and Without Dysplasia/Adenocarcinoma |
title_full_unstemmed | Clinical and Endoscopic Differences Between Patients With Barrett’s Esophagus With and Without Dysplasia/Adenocarcinoma |
title_short | Clinical and Endoscopic Differences Between Patients With Barrett’s Esophagus With and Without Dysplasia/Adenocarcinoma |
title_sort | clinical and endoscopic differences between patients with barrett’s esophagus with and without dysplasia/adenocarcinoma |
topic | Gastroenterology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617646/ https://www.ncbi.nlm.nih.gov/pubmed/37916254 http://dx.doi.org/10.7759/cureus.46323 |
work_keys_str_mv | AT valdovinosandracafrancisco clinicalandendoscopicdifferencesbetweenpatientswithbarrettsesophaguswithandwithoutdysplasiaadenocarcinoma AT bartnickinavarreteisaac clinicalandendoscopicdifferencesbetweenpatientswithbarrettsesophaguswithandwithoutdysplasiaadenocarcinoma AT bernalmendezambrosior clinicalandendoscopicdifferencesbetweenpatientswithbarrettsesophaguswithandwithoutdysplasiaadenocarcinoma AT rafaelbarretozunigarafael clinicalandendoscopicdifferencesbetweenpatientswithbarrettsesophaguswithandwithoutdysplasiaadenocarcinoma AT romanomuniveadrianaf clinicalandendoscopicdifferencesbetweenpatientswithbarrettsesophaguswithandwithoutdysplasiaadenocarcinoma AT gamboadominguezarmando clinicalandendoscopicdifferencesbetweenpatientswithbarrettsesophaguswithandwithoutdysplasiaadenocarcinoma AT elizondoriverajavier clinicalandendoscopicdifferencesbetweenpatientswithbarrettsesophaguswithandwithoutdysplasiaadenocarcinoma AT brisenogarciadaniel clinicalandendoscopicdifferencesbetweenpatientswithbarrettsesophaguswithandwithoutdysplasiaadenocarcinoma AT tellezavilafelixi clinicalandendoscopicdifferencesbetweenpatientswithbarrettsesophaguswithandwithoutdysplasiaadenocarcinoma |